NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-351-2013-0-US-01 HER2-SPECIFIC MONOCLONAL ANTIBODIES AND CONJUGATES THEREOF US 61/833,732 Abandoned
NIDDK E-456-2013-0-US-01 Method of Increasing the Amount of Fetal Hemoglobin in a Mammal US 61/833,275 Abandoned
NCI E-039-2011-0-US-06 Chimeric Rabbit/Human ROR1 Antibodies US National Stage 13/990,977 9758586 Issued PDF
NCI E-081-2015-1-CA-03 HUMAN BISPECIFIC EGFRVIII ANTIBODY ENGAGING MOLECULES CA National Stage 2876133 Abandoned
NCI E-269-2010-0-US-09 Anti-SSX-2 T Cell Receptors and Related Materials and Methods of Use US National Stage 13/820,802 9345748 Issued PDF
NCATS E-203-2012-0-PCT-02 METHODS AND COMPOSITIONS FOR THE INHIBITION OF PIN1 PCT PCT PCT/US2013/044747 Expired
NCI E-081-2015-1-PCT-01 HUMAN BISPECIFIC EGFRVIII ANTIBODY ENGAGING MOLECULES PCT PCT COMB PCT/US2013/044672 Expired
NCI E-081-2015-1-EP-04 HUMAN BISPECIFIC EGFRVIII ANTIBODY ENGAGING MOLECULES EP National Stage 13800038.5 Abandoned
NCATS E-203-2012-0-CA-04 METHODS AND COMPOSITIONS FOR THE INHIBITION OF PIN1 CA National Stage 2875798 Abandoned
NCATS E-203-2012-0-AU-03 METHODS AND COMPOSITIONS FOR THE INHIBITION OF PIN1 AU National Stage 2013271378 Abandoned
NCATS E-257-2010-0-IL-06 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators IL National Stage 226767 Issued
NCI E-269-2011-0-US-03 KITS FOR DETECTING AND MONITORING ENDOCRINE DISRUPTING CHEMICALS (EDCS) US ORD 13/912,071 9040248 Issued PDF
NCI E-269-2011-0-PCT-02 KITS FOR DETECTING AND MONITORING ENDOCRINE DISRUPTING CHEMICALS (EDCS) PCT PCT PCT/US2013/044569 Expired
NCI E-269-2011-0-EP-04 KITS FOR DETECTING AND MONITORING ENDOCRINE DISRUPTING CHEMICALS (EDCS) EP National Stage 13730754.2 Abandoned
NCATS E-257-2010-0-CA-04 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators CA National Stage 2820362 Issued
NCI E-315-2007-0-US-04 Method of Inhibiting ABCG2 and Other Treatment Methods US DIV 13/910,238 9314448 Issued PDF
NCI E-292-2007-0-HK-08 DELETIONS IN DOMAIN II OF PSEUDOMONAS EXOTOXIN A THAT REDUCE NON-SPECIFIC TOXICITY HK National Stage 13106628.2 Abandoned
NCI E-034-2013-0-US-01 Monomeric Griffithsin Tandemers US 61/831,336 Abandoned
NICHD E-032-2008-0-US-04 Use Of Saccharides Cross-reactive With Bacillus Anthracis Spore Glycoprotein As A Vaccine Against Anthrax US DIV 13/909,992 8926986 Abandoned PDF
NIAID E-323-2005-3-HK-13 Influenza Hemagglutinin And Neuraminidase Variants HK EP 13106582.6 Abandoned
NIBIB E-314-2013-0-CN-02 Octapod Iron Oxide Nanoparticles As High-Performance T2 Contrast Agents For Magnetic Resonance Imaging CN National Stage 201380077163.3 Abandoned
NIBIB E-314-2013-0-EP-03 Octapod Iron Oxide Nanoparticles As High-Performance T2 Contrast Agents For Magnetic Resonance Imaging EP National Stage 13886302.2 Abandoned
NIBIB E-314-2013-0-PCT-01 Octapod Iron Oxide Nanoparticles As High-Performance T2 Contrast Agents For Magnetic Resonance Imaging PCT PCT PCT/CN2013/076645 Expired
NCI E-124-2011-0-US-02 Anti-podoplanin Antibodies And Methods Of Use US National Stage 13/991,308 Abandoned
NCI E-136-2012-0-SG-06 High-Affinity Monoclonal Antibodies To Glypican-3 And Use Thereof SG National Stage 11201407972R Issued
NHLBI E-209-2007-0-US-04 MRI GUIDEWIRE US DIV 13/907,743 9259556 Issued PDF
NCATS E-187-2009-2-US-02 Organic Compounds US National Stage 13/810,587 9066948 Abandoned PDF
NCI E-136-2012-0-PCT-02 High-Affinity Monoclonal Antibodies To Glypican-3 And Use Thereof PCT PCT PCT/US2013/043633 Expired
NHGRI E-217-2007-0-CA-03 N-ACETYL MANNOSAMINE OR DERIVATIVES THEREOF FOR USE IN TREATING A KIDNEY DISORDER IN A MAMMAL CA National Stage 2680842 Issued
NCI E-039-2011-0-IT-09 Chimeric Rabbit/Human ROR1 Antibodies IT EP 11791733.6 Issued
NCI E-039-2011-0-GB-11 Chimeric Rabbit/Human ROR1 Antibodies GB EP 11791733.6 Issued
NCI E-039-2011-0-ES-10 Chimeric Rabbit/Human ROR1 Antibodies ES EP 11791733.6 Issued
NCI E-039-2011-0-DE-07 Chimeric Rabbit/Human ROR1 Antibodies DE EP 11791733.6 Issued
NCI E-039-2011-0-FR-08 Chimeric Rabbit/Human ROR1 Antibodies FR EP 11791733.6 Issued
NIDDK E-194-2012-0-PCT-02 EUKARYOTIC TRANSPOSASE MUTANTS AND TRANSPOSON END COMPOSITIONS FOR MODIFYING NUCLEIC ACIDS AND METHODS FOR PRODUCTION AND USE IN THE GENERATION OF SEQUENCING LIBRARIES PCT PCT PCT/US2013/043138 Expired
NIA E-146-1993-0-US-57 METHOD OF TREATING ATHEROSCLEROSIS OR RESTENOSIS USING MICROTUBULE STABILIZING AGENT US CON 13/904,928 Abandoned
NIDCR E-015-2002-1-US-08 Mammalian Sweet and Amino Acid Heterodimeric Taste Receptors Comprising T1R3 and T1R1 US CON 13/903,820 9347935 Expired PDF
NINDS E-251-2005-1-US-04 Vibro-tactile Stimulation To The Neck To Enhance Volitional Control Of Swallowing, Speech Or Voice In Patients With Motor Control Disorders US CON 13/902,263 8852074 Issued PDF
NIA E-139-2012-2-CA-03 METHODS OF REGULATING CANNABINOID RECEPTOR ACTIVITY-RELATED DISORDERS AND DISEASES CA National Stage 2874655 Issued
NIA E-139-2012-2-AU-02 METHODS OF REGULATING CANNABINOID RECEPTOR ACTIVITY-RELATED DISORDERS AND DISEASES AU National Stage 2013266235 Issued
NIA E-139-2012-2-EP-04 METHODS OF REGULATING CANNABINOID RECEPTOR ACTIVITY-RELATED DISORDERS AND DISEASES EP National Stage 13727753.9 Issued
NIAMS E-216-2010-0-JP-04 Compositions and Methods for Treating and Preventing Lupus JP National Stage 2013-540939 Issued
NIA E-139-2012-2-PCT-01 METHODS OF REGULATING CANNABINOID RECEPTOR ACTIVITY-RELATED DISORDERS AND DISEASES PCT PCT COMB PCT/US2013/042457 Expired
NCI E-113-2003-1-US-04 Target Activated Microtransfer US CON 13/901,394 Abandoned
NCI E-105-2012-0-CA-04 Murine Anti-NY-ESO-1 T Cell Receptors CA National Stage 2874486 Issued
NIAMS E-216-2010-0-CA-03 Compositions and Methods for Treating or Preventing Lupus CA National Stage 2818712 Issued
NCI E-105-2012-0-EP-06 Murine Anti-NY-ESO-1 T Cell Receptors EP National Stage 13726389.3 Issued
NCI E-105-2012-0-AU-03 Murine Anti-NY-ESO-1 T Cell Receptors AU National Stage 2013266421 Issued
NCI E-105-2012-0-PCT-02 Murine Anti-NY-ESO-1 T Cell Receptors PCT PCT PCT/US2013/042162 Expired
NCI E-125-2011-2-US-02 Antibodies And Immunotoxins Reactive With Human Gangliosides 3'6'iso-LM1 And 3'6'iso-LD1 And Methods Of Use US National Stage 13/988,696 9441048 Issued PDF